(Q48320507)

10 February 2018

title

Biology and evolution of poorly differentiated neuroendocrine tumors. (English)

1 reference

10 February 2018

author

Francesca Demichelis

3

1 reference

10 February 2018

Mark Rubin

4

1 reference

10 February 2018

Himisha Beltran

2

object named as

Himisha Beltran

1 reference

10 February 2018

David S Rickman

1

object named as

David S Rickman

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 June 2017

1 reference

10 February 2018

published in

Nature Medicine

1 reference

10 February 2018

volume

23

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

1-10

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1038/nm.4341

exact match

0 references

cites work

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

1 reference

Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors

21 January 2018

1 reference

Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas

21 January 2018

1 reference

Neuroendocrine tumours--challenges in the diagnosis and classification of pulmonary neuroendocrine tumours.

21 January 2018

1 reference

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

21 January 2018

1 reference

Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms

21 January 2018

1 reference

Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification

21 January 2018

1 reference

Neuroendocrine tumors of the pancreas: current concepts and controversies.

21 January 2018

1 reference

Neuroendocrine tumors of the gynecologic tract: select topics.

21 January 2018

1 reference

Whole-genome landscape of pancreatic neuroendocrine tumours.

21 January 2018

1 reference

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.

21 January 2018

1 reference

Comprehensive genomic profiles of small cell lung cancer

21 January 2018

1 reference

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

21 January 2018

1 reference

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.

21 January 2018

1 reference

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

21 January 2018

1 reference

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

21 January 2018

1 reference

Comprehensive molecular profiling of lung adenocarcinoma

21 January 2018

1 reference

Somatic mutations affect key pathways in lung adenocarcinoma

21 January 2018

1 reference

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

21 January 2018

1 reference

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma

21 January 2018

1 reference

Clonal integration of a polyomavirus in human Merkel cell carcinoma

21 January 2018

1 reference

Models of neuroendocrine prostate cancer

21 January 2018

1 reference

Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model

21 January 2018

1 reference

Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice

21 January 2018

1 reference

Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice.

21 January 2018

1 reference

PTEN is a potent suppressor of small cell lung cancer.

21 January 2018

1 reference

The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer

21 January 2018

1 reference

Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing

21 January 2018

1 reference

Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma

21 January 2018

1 reference

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

21 January 2018

1 reference

The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung

21 January 2018

1 reference

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

21 January 2018

1 reference

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

21 January 2018

1 reference

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model

21 January 2018

1 reference

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model

21 January 2018

1 reference

A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells

21 January 2018

1 reference

Hepsin promotes prostate cancer progression and metastasis

21 January 2018

1 reference

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

21 January 2018

1 reference

Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice

21 January 2018

1 reference

An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse

21 January 2018

1 reference

Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model

21 January 2018

1 reference

Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

21 January 2018

1 reference

Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition

21 January 2018

1 reference

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer

21 January 2018

1 reference

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

21 January 2018

1 reference

Neurofibromatosis type 1 gene mutations in neuroblastoma

21 January 2018

1 reference

Targeted expression of MYCN causes neuroblastoma in transgenic mice

21 January 2018

1 reference

Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma

21 January 2018

1 reference

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

21 January 2018

1 reference

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

21 January 2018

1 reference

MYC, MAX, and small cell lung cancer.

21 January 2018

1 reference

A framework for identification of actionable cancer genome dependencies in small cell lung cancer

21 January 2018

1 reference

Targets in small cell lung cancer

21 January 2018

1 reference

Molecular genetics of small cell lung carcinoma

21 January 2018

1 reference

Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer

21 January 2018

1 reference

Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer

21 January 2018

1 reference

The Sema domain of Met is necessary for receptor dimerization and activation

21 January 2018

1 reference

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

21 January 2018

1 reference

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases

21 January 2018

1 reference

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

21 January 2018

1 reference

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

21 January 2018

1 reference

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

21 January 2018

1 reference

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.

21 January 2018

1 reference

The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept

21 January 2018

1 reference

The origin of neuroendocrine tumors and the neural crest saga

21 January 2018

1 reference

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

21 January 2018

1 reference

Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach

21 January 2018

1 reference

Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

21 January 2018

1 reference

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

21 January 2018

1 reference

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

21 January 2018

1 reference

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease

21 January 2018

1 reference

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

21 January 2018

1 reference

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

Proposed morphologic classification of prostate cancer with neuroendocrine differentiation

21 January 2018

1 reference

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

21 January 2018

1 reference

Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP

21 January 2018

1 reference

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression

21 January 2018

1 reference

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

21 January 2018

1 reference

A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49

21 January 2018

1 reference

From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

21 January 2018

1 reference

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

21 January 2018

1 reference

Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles

21 January 2018

1 reference

Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway

21 January 2018

1 reference

Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis

21 January 2018

1 reference

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.

21 January 2018

1 reference

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

21 January 2018

1 reference

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

21 January 2018

1 reference

Drugging the p53 pathway: understanding the route to clinical efficacy

21 January 2018

1 reference

Targeting mutant p53 in cancer: a long road to precision therapy.

21 January 2018

1 reference

Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma

21 January 2018

1 reference

Drugging MYCN through an allosteric transition in Aurora kinase A

21 January 2018

1 reference

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.

21 January 2018

1 reference

Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer

21 January 2018

1 reference

Punctuated evolution of prostate cancer genomes

21 January 2018

1 reference

Genomic analyses identify molecular subtypes of pancreatic cancer

21 January 2018

1 reference

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

21 January 2018

1 reference

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

21 January 2018

1 reference

The Molecular Taxonomy of Primary Prostate Cancer

21 January 2018

1 reference

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

21 January 2018

1 reference

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

21 January 2018

1 reference

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

The prenatal origins of cancer

21 January 2018

1 reference

Differential expression of myc family genes during murine development

21 January 2018

1 reference

Apoptosis in the nervous system

21 January 2018

1 reference

21 January 2018

Reprogramming to resist.

1 reference

Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?

21 January 2018

1 reference

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification

21 January 2018

1 reference

7 January 2021

Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer

1 reference

7 January 2021

N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling

1 reference

7 January 2021

Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

1 reference

7 January 2021

Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)

1 reference

7 January 2021

Pathologic progression of autochthonous prostate cancer in the TRAMP model

1 reference

7 January 2021

Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model

1 reference

7 January 2021

A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies

1 reference

7 January 2021

Activated expression of the N-myc gene in human neuroblastomas and related tumors

1 reference

7 January 2021

5' flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice

1 reference

7 January 2021

Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells

1 reference

7 January 2021

Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma

1 reference

7 January 2021

Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: association with tumor cell proliferation prior to recurrence

1 reference

7 January 2021

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

1 reference

7 January 2021

Neuroendocrine differentiation in human prostatic tumor models

1 reference

12 December 2020

Analysis of endoderm formation in the avian blastoderm by the use of quail-chick chimaeras. The problem of the neurectodermal origin of the cells of the APUD series

1 reference

12 December 2020

Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors

1 reference

12 December 2020

Metastatic prostate cancer in a transgenic mouse

1 reference

12 December 2020

Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo

1 reference

12 December 2020

Molecular genetic characterization of neuroendocrine lung cancer cell lines

1 reference

12 December 2020

Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.

1 reference

12 December 2020

A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

1 reference

12 December 2020

WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.4341

1 reference

10 February 2018

1 reference

10 February 2018